Product image of Xevudy (Sotrovimab) supplied by GNH India

Xevudy

Active Ingredient:
Sotrovimab
Origin:
EU

Xevudy (Sotrovimab)

Xevudy (sotrovimab) is an antiviral medication used to treat mild-to-moderate COVID-19 in adults and adolescents. Administered via intravenous infusion, it targets SARS-CoV-2 to reduce symptom severity. This overview covers key details for informed use. Seek medical guidance for personalized advice.

Manufacturer / TM Owner

Glaxosmithkline Trading Services Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Xevudy (sotrovimab) is designed for people with confirmed COVID-19 who are at high risk of severe illness. It works by binding to the spike protein of the virus, helping the immune system neutralize the infection. This treatment is intended for early use in mild-to-moderate cases to prevent progression. It is not a substitute for vaccination.

Side Effects

  • After receiving Xevudy, some patients report temporary relief from COVID-19 symptoms such as fever, cough, or fatigue. The infusion process may cause mild discomfort at the injection site. Most effects are short-lived and monitored during administration. Individual responses vary based on health status and timing of treatment.

Precautions & Warnings

  • Xevudy should be administered under medical supervision in a healthcare setting. Patients with a history of severe allergic reactions to its components should avoid it. Inform your provider about current medications or conditions before treatment. Stay hydrated and follow post-infusion care instructions as directed.

Avoid Interactions

  • Xevudy may interact with other monoclonal antibodies or immunosuppressants, potentially altering effectiveness. Caution is advised when combining with drugs that affect the immune system. No specific food or alcohol restrictions are noted, but discuss all medications with your healthcare provider. Monitor for unexpected reactions during and after infusion.

Frequently Asked Questions

Xevudy is used to treat mild-to-moderate COVID-19 in adults and adolescents at high risk of severe illness.

Xevudy is given as a single-dose intravenous infusion in a healthcare setting.

No, Xevudy is not a preventive treatment; it is used to treat existing infections.

Common effects may include infusion-related reactions or mild discomfort at the injection site.

No, Xevudy requires a prescription and is administered by a healthcare professional.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sotrovimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT